Fair value (multi-method)
Four independent methods triangulate what ABT is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$99.03
Method range
$20.33 – $170.65
median $110.75
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $99.03 | -1.64% |
| Exit multiple | $170.65 | +69.50% |
| Analyst target | $122.46 | +21.63% |
| Graham number | $20.33 | -79.81% |
- Forward DCF$99.03
- Exit multiple$170.65
- Analyst target$122.46
- Graham number$20.33
Stock price
$100.68
FCF / share (TTM)
$0.52
3Y FCF CAGR
-3.3%
Fair value @ hist. growth
$6.71
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
32.0%
per year over your projection horizon
Margin of safety -1,400.2% vs hist-growth DCF
Historical 3Y CAGR
-3.3%
Your model implies
32.0%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -3% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.6% | 27.2% | 25.7% | 24.0% | 21.9% | 19.5% |
| 6.6% | 30.9% | 29.7% | 28.3% | 26.8% | 25.0% |
| 7.6% | 34.1% | 33.1% | 32.0% | 30.8% | 29.4% |
| 8.6% | 37.1% | 36.2% | 35.3% | 34.2% | 33.1% |
| 9.6% | 39.8% | 39.1% | 38.2% | 37.4% | 36.4% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
Net debt
$6.55B
Total debt − cash
Beta
0.61
Vs market benchmark
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.44% TTM
- Dividend Profile2.46% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.